Registration Policy

All policies and Terms of Registration are adopted in consideration of, and in the best interest of, conference attendees, exhibitors, event co-sponsors and the conference venue. As a condition of registration, you agree to all of the terms and policies contained herein, as well as all other reasonable policies promulgated by the Conference Organisers.

Select a section

1. Registration Processing
2. Transferring of Registration
3. Registration Cancellations/Refunds
4. Event Cancellation
5. Coronavirus (COVID-19)
6. Speaker Substitution
7. Identification
8. Name Badges
9. Photographs/Videos
10. Delegate Information
11. Conference Etiquette
12. Smoking
13. Marketing Activities
14. Consumption of Alcohol
15. Limitation of Liability
16. How To Contact Us

1. Registration Processing

Registrations received without full payment prior to the deadline for Early bird pricing will not automatically qualify for the discounted rate. The applicable rate will be assessed at the time full payment is received. Note: Registrations received without payment will not be processed until payment is received.
Back to top

2. Transferring of Registration

Delegates who are unable to attend the conference may send another individual of their choice, provided we receive the transferee’s registration application at least three (3) weeks prior to the start of the conference. Approval of this transfer is at the discretion of the Conference Organisers.
Back to top

3. Registration Cancellations/Refunds

All registration cancellations must be received in writing five weeks before the first day of the conference (or delivered by e-mail to the address provided in the Contact Us section below). A refund of the conference fee, minus a $75 administrative fee, will be given for cancellations that are received in a timely manner. Refund requests received after this date will be considered on an individual basis.
Back to top

4. Event Cancellation

The Conference Organisers reserve the right to cancel this event without liability, and the total amount of any and all liability of the organisers will be limited to a refund of any registration fees. Any fees associated with cancellation of travel or housing reservations is the exclusive responsibility of conference attendees.
Back to top

5. Global Pandemics

The health and safety of delegates, speakers, exhibitors and staff remains our highest priority. Should a global pandemic or other significant public health event arise that impacts the conference, the Organising Committee will monitor advice issued by the Australian Government Department of Health, Disability and Ageing and relevant State health authorities, and implement appropriate measures to protect attendees. These may include enhanced hygiene protocols, changes to venue operations, adjustments to the conference format, or, if necessary, postponement or cancellation. Delegates will be kept informed of any changes promptly and are encouraged to refer to the Australian Government’s travel health advice at Department of Health – Travel Health and the latest travel advisories from Smartraveller when planning their travel. All decisions will be guided by official public health advice and a commitment to delivering a safe and successful event.
Back to top

6. Speaker Substitution

The Conference Organisers reserve the right to substitute an equally qualified speaker in case of an emergency or cancellation. The Conference Organisers make no endorsements of any presentation or product and have no duty of due diligence with respect to presenters, exhibitors, or sponsors.
Back to top

7. Identification

Attendees are asked to present their Registration Confirmation document at registration in order to collect registration materials.
Back to top

8. Name Badges

Delegates are reminded that it is important to wear your badge at all times. This allows you uncomplicated access to conference events. However, for security reasons, please remember to remove your badge when you are outside the conference events and venues.
Back to top

9. Photographs/Videos

Photographs, video and audio recordings will be taken during the Conference and associated events to produce a record of the Conference. Some content will be made available to those who cannot attend.

You hereby grant the Conference Organisers an irrevocable, worldwide, royaltyfree, fully-paid up license to reproduce, copy, display, perform, or otherwise use any photos, videos or audio recordings taken of you by the Conference Organisers or their agents for promotional use (i.e. brochures, association publications, web-based media – blogs, websites, e-newsletters). You hereby release and hold harmless the Conference Organisers and their agents and assigns from all claims, demands, causes of action and liability related to said use of the material. Please contact us in advance of the conference if this poses a problem for you.
Back to top

10. Delegate Information

The Conference Organisers may provide a list of delegate contact details to the conference sponsors. Should you not wish your details to be provided to such conference sponsors, please advise us using one of the means provided in the Contact Us section below. The delegate list will not be made available to any parties other than specified conference sponsors, and will not be traded or sold in any form.
Back to top

11. Conference Etiquette

To make the conference experience an enjoyable event for all attendees, we ask that you please keep the following in mind:

  • As a courtesy to our speakers, please refrain from using mobile phones during presentations, unless you are participating in live polling via a conference app.
  • Participants of this conference are in attendance to learn. Therefore, in consideration of all attendees we ask that you please hold any conversations outside session rooms.
Back to top

12. Smoking

This event is being held at a non-smoking venue. Designated smoking areas are available, please contact venue staff for details.
Back to top

13. Marketing Activities

Attendees are prohibited from distributing materials or otherwise marketing themselves or businesses at the conference unless they are a paid exhibitor or sponsor. This applies to all areas of the conference venue, including the exhibition areas, session rooms, and break areas. Paid Sponsors and Exhibitors may exhibit in the exhibition area, and must limit marketing activities to their designated area (confines of their booth) or other paid sponsorship event.
Back to top

14. Consumption of Alcohol

The Conference Organisers expressly disclaim any liability arising out of attendee’s consumption of alcoholic beverages at the conference or associated events. Certain conference events, receptions and parties will serve alcoholic beverages, and conference participants are responsible for their own well being. Persons under the age of 18 or those deemed to be intoxicated will be denied alcoholic beverages. The Conference Organisers expressly disclaim liability for any acts or omissions of attendees resulting from excessive drinking, recklessness or negligence on the part of any conference participant(s).
Back to top

15. Limitation of Liability

The Conference Organisers expressly disclaim liability for acts or omissions of the organisers and for third parties including facilities, suppliers, and exhibitors in conjunction with the event, or for the safety of any attendee while in transit to or from this event. The Conference Organisers shall not be liable for any delays, interruption of services, or failure in performance resulting directly or indirectly from any cause or circumstance beyond the reasonable control of the organisers. This includes but is not limited to, failure of transportation, weather, accidents, fires, electrical failures, strikes, labour disputes, postal delays, explosions, government orders or regulations, war, terrorism, or acts of God. Attendees who purchase non-refundable airline tickets do so at their own risk.

Attendees/Exhibitors/Sponsors at the conference agree to indemnify, defend and hold harmless the Conference Organisers and their officers, directors, and agents against all claims arising out of actions or omissions of Attendees/Exhibitors/ Sponsors at or in connection with the Temtia X event except for the Conference Organisers own gross negligence or willful misconduct. The Conference Organisers agree to indemnify and hold harmless Attendees/Exhibitors/Sponsors against all claims arising out of the acts of omissions of the conference Organisers and their officers, directors, and agents in connection with the Temtia X event except for Attendee’s/Exhibitor’s/Sponsor’s own gross negligence or willful misconduct.
Back to top

16. How To Contact Us

If you have a query in relation to this Privacy Policy or you would like to notify Small Talk Events that you no longer wish to receive marketing material from us, access or correct your Personal Information or to make a complaint about Small Talk Events’ handling of your Personal Information, please contact Small Talk Events as follows:

Small Talk Events
PO Box 490
West Ryde NSW 1685
Australia
T 0422 116 849
E info@smalltalkevents.com.au
Back to top

Conference Organisers: the Australasian Wound and Tissue Repair Society, and Small Talk Events Pty Ltd.

Profile photo

Quenten Schwartz
Head of the Neurovascular Research Laboratory, Centre for Cancer Biology, Adelaide University

Dr. Quenten Schwarz is a developmental neuroscientist heading the Neurovascular Research Laboratory at the Centre for Cancer Biology. Following a PhD in Human Genetics obtained from the Univresity of Adelaide he relocated to London to undertake Postdoctoral training at University College London. In this time he investigated the molecular control of neuronal and vascular development. Since returning to Australia to establish his laboratory in 2010 he has been awarded several NHMRC project grants, an NHMRC CDA Fellowship and is a current National Heart Foundation Future Leader Fellow.

His work is primarily focused on understanding how interactions between neural crest cells, neurons and endothelial cells control morphogenesis of embryonic structures including the craniofacial skeleton, heart and brain. In the past 5 years he has 24 publications in high-impacting journals, including 14 as first or senior author. In recognition of his achievements he has been honoured with several prestigious awards, including the 2011 South Australia Bioinnovation Award, the 2014 AW Campbell Award by the Australasian Neuroscience Society for early career research excellence, and the 2015 South Australian ASMR Leading Light Award.

Profile photo

Simon Cool
Chief Executive Officer of the SMART CRC

Professor Simon Cool is Chief Executive Officer of the SMART CRC (Solutions for Manufacturing Advanced Regenerative Therapies), leading national efforts to accelerate the development and translation of regenerative therapies into tangible health solutions that improve lives. With more than three decades of experience, he is focused on forging collaborations across industry, government and academia to address critical manufacturing challenges in regenerative therapies through multidisciplinary innovation that accelerates patient access to life-changing therapies. His work in this area supports the development of the skilled workforce needed to support a rapidly growing regenerative therapies sector.

Professor Cool is a Professor of Biomedical Engineering and the inaugural chair of the AusBiotech and Medicines AustraliaAdvanced Therapies Advisory Group. He is also the former director of the Advanced Cell Therapy Manufacturing Initiative at The University of Queensland (UQ).

Prior to returning to UQ in 2022, he spent nearly two decades at the Institute of Molecular and Cell Biology (IMCB), A*STAR Singapore, where he progressed from Principal Investigator to Research Director.

An internationally recognised leader, Professor Cool holds over 50 granted patents and more than 150 publications, while fostering global partnerships that accelerate innovation, translation, and real-world impact.

Profile photo

Snehlata Kumari
Senior Research Fellow, Frazer Institute, The University of Queensland

Dr Snehlata Kumari is a group leader and head of the Skin Inflammation and Immunity Laboratory at the University of Queensland, Frazer Institute in Brisbane, Australia. She is a board member and co-chair of the Scientific Program and Award Committee of the Australasian Society for Dermatology Research (ASDR), and a councillor of the International Psoriasis Council (IPC).

Her research focuses on uncovering the mechanisms of skin inflammation and paving the way for the translation of new, effective, and safe therapies for skin diseases, including psoriasis, atopic dermatitis, and hidradenitis suppurativa. Her research findings, defining novel mechanisms of skin inflammation initiation and persistence, were published in top-tier journals, including Nature, Nature Communications, and Immunity.

She has received multiple international recognitions, including the Christina Fleishmann Award from the International Cytokine and Interferon Society (ICIS) for Young Women Investigator, and honours from the European Society for Dermatological Research (ESDR), the Japanese Society for Investigative Dermatology (JSID) and the German National Academy of Sciences.

Profile photo

Jess Frith
Professor & Deputy Head, Department of Materials Science & Engineering, Monash University

Jess is Professor and Deputy Head of the Department of Materials Science and Engineering at Monash University, where she leads an interdisciplinary research group at the interface of cell biology and tissue engineering. After completing her PhD at the University of York (UK), she undertook postdoctoral research at the Australian Institute for Bioengineering and Nanotechnology before joining Monash in 2015. Her research focuses on understanding mechanobiology and developing bioengineered systems, such as hydrogels and microstructured materials, to control cell proliferation, differentiation, and function for improved tissue regeneration. Professor Frith has been recognised with several prestigious awards, including an ARC Discovery Early Career Research Award (2013), a Young Tall Poppy Science Award (2017), and an ARC Future Fellowship (2024).

Profile photo

Khoon Lim
University of Sydney, Australia

Professor Khoon Lim is currently an Australian Research Council Future Fellow and the Co-Director of the Sydney Biomanufacturing Incubator at the University of Sydney, Australia. His research focuses on using light-activated macromolecular chemistry to design dynamic biomaterials for tissue engineering and regenerative medicine applications. These include musculoskeletal regeneration, cardiovascular health, chronic wounds and in vitro tissue models (cancer and aging). He has generated >120 journal publications and raised a total of >$13 Million research grant funding ($8 Million as CIA). He is the Past-President of the Australasian Society for Biomaterials & Tissue Engineering, Treasurer of the International Society for Biofabrication and Committee Member of Standards Australia (HE-012 Surgical Implants). He has won >20 competitive national/international awards, included in the World’s Top 2% Scientist List by Stanford University for 2022 – 2025. He currently serves on the Editorial Board of Biofabrication, Advanced Chemical Engineering, Advanced NanoBiomed Research, Tissue Engineering Part B, RSC Biomaterials Science, Macromolecular Bioscience and Journal of Materials Science: Materials in Medicine. His research has also led to commercialisation of biomaterials licensed to a US-based company and commercial contracts with industry partners.

Email – khoon.lim@sydney.edu.au
Twitter/X – @Khoonono
LinkedIn

Profile photo

Joanneke Maitz
Burns Surgeon-scientist at the ANZAC Research Institute, Concord Hospital

Specialist surgeon in burns, plastics, and reconstruction, and an accomplished researcher in translational burn injury and skin tissue engineering. She leads the Burns & Reconstructive Surgery Research Group at the ANZAC Research Institute, Concord Hospital and is a Clinical Senior Lecturer at the University of Sydney.

Dr Maitz’s research focuses on advancing bioengineered solutions for burns treatment and reconstructive surgery, with emphasis on next-generation skin substitutes and improving outcomes for patients with severe soft-tissue loss. In 2025, the Concord Hospital Burns Unit received the NSW Health Innovation Award in recognition of this landmark research program. The Unit’s pioneering 3D-bioprinted skin project, now in a first-in-human clinical trial, represents a major step forward in personalised regenerative medicine. Initially developed for burns victims, this technology has the potential to transform treatment for a wide range of soft tissue defects, offering new hope for patients who previously had limited reconstructive options.

Profile photo

Yiwei Wang
Distinguished Professor at Nanjing University of Chinese Medicine, China

Professor Yiwei Wang is a Distinguished Professor at Nanjing University of Chinese Medicine, China. She received her PhD from Kingston University London and completed postdoctoral training at the UK National Physical Laboratory and the University of Queensland. She previously served as Principal Research Scientist in the Burns and Plastic Surgery Unit at Concord Hospital, affiliated with the University of Sydney. Her research focuses on tissue engineering, wound healing, scar management, and drug delivery systems. Professor Wang has published over 100 SCI papers in leading journals and currently serves on the editorial boards of  Burns & Trauma and Asian Journal of Pharmaceutical Sciences. 

Profile photo

Artur Schmidtchen
Professor and Senior Consultant in Dermatology at Lund University and Lund University Hospital, Sweden

Artur Schmidtchen, MD, PhD is Professor and Senior Consultant in Dermatology at Lund University and Lund University Hospital, Sweden, where he leads the Division of Dermatology and Venereology. His research bridges basic science and clinical innovation, focusing on the role of innate immunity in wound healing, infection, and inflammation. Applications include novel strategies for treating dysfunctional wound healing and systemic inflammatory diseases.

His work is grounded in the concept that the human body encodes innate immune regulators within its own proteins, released dynamically during proteolysis. Using an integrated approach combining mass spectrometry, computational modeling, biochemistry, microbiology, cell biology, and translational in vivo models, his lab has developed new therapeutic and diagnostic tools.

Prof. Schmidtchen’s group discovered thrombin-derived C-terminal peptides (TCPs), including TCP-25, which exert dual effects—direct antimicrobial activity and anti-inflammatory effects mediated via CD14/TLR inhibition (Nat Commun, 2018). TCP-25 has demonstrated efficacy in large animal wound models (Sci Transl Med, 2020), successfully completed Phase I clinical trials (Orphanet J Rare Dis, 2025; Clin Transl Sci, 2026), and is currently in Phase II/III clinical development for treatment of epidermolysis bullosa (EB). In 2024, TCP-25 also received FDA Orphan Drug Designation for EB. Building on the TCP structure, his team designed stapled peptide mimetics with improved systemic stability and efficacy in preclinical models of sepsis and systemic inflammation (Nat Commun, 2023). In parallel, his group has developed peptidomic methods for identifying proteolytic signatures and infection endotypes in wounds, supporting the development of precision diagnostics (eLife, 2021; Nat Commun, 2024).

Prof. Schmidtchen has held international academic roles, including Professor and Scientific Director at Nanyang Technological University, Singapore, and Affiliated Professor at the University of Copenhagen. He has published over 180 peer-reviewed articles and is the founder of Xinnate AB, Transient Pharma AB, and in2cure AB, which translate peptide-based discoveries into clinical applications.

Profile photo

Sabine Werner
Professor of Cell Biology at the Swiss Technical University (ETH) Zürich

Sabine Werner is Professor of Cell Biology at the Swiss Technical University (ETH) Zurich. She studied Biochemistry at the Universities of Tubingen and Munich, Germany, and earned her Ph.D. at the University of Munich, after having completed her dissertation at the Max-Planck-Institute of Biochemistry in Martinsried, Germany, in the field of cancer research. As a postdoctoral researcher she worked at the University of California San Francisco, where she studied the functions and mechanisms of action of growth factors in tissue repair. After her return to Europe and until her move to Zurich, she was a group leader at the Max-Planck-Institute of Biochemistry in Martinsried and Associate Professor of Biochemistry at the Ludwig-Maximilians-University of Munich.

Her group studies the molecular and cellular mechanisms of wound repair and the parallels to inflammatory skin diseases and cancer with a focus on the roles of growth factors and their downstream targets in these processes.

Sabine Werner is an elected member of EMBO, the German Academy of Sciences (Leopoldina), and the European Academy of Sciences (EurASc), and the chair of the interdisciplinary skin research consortium SKINTEGRITY.CH.

Profile photo

Rob Fitridge
Vascular Surgeon at the Royal Adelaide and The Queen Elizabeth Hospitals

Professor Rob Fitridge is a Vascular Surgeon at the Royal Adelaide and The Queen Elizabeth Hospitals.

He is a member of the International Working Group for the Diabetic Foot (and co-chair of its Peripheral Arterial Disease guideline writing group which is collaborating with the European Society for Vascular Surgery [ESVS] and the Society for Vascular Surgery [SVS]). He is a member of the steering committee for the Global Guidelines for Chronic Limb-threatening Ischaemia (CLTI) and has also been an author of the ESVS Asymptomatic PAD and Claudication guideline.

He is managing editor for the fourth edition of “Mechanisms of Vascular Disease: A Textbook for Vascular Specialists”, which is a core reference for vascular traning.

Prof Fitridge has a research interest in wound healing in diabetes, assessment and management of diabetes-related foot complications and has a major interest in optimising care for rural, remote and First Nations people with DRFCs and CLTI using advanced telehealth.

Profile photo

Zlatko Kopecki
Industry Research Fellow, Adelaide University

Dr. Kopecki is a past NHMRC ECR Fellow, inaugural Future Industries Institute (FII) Foundation Fellow, Mid-Career Fellow in Childhood Wound Infections at University of South Australia and is a current Industry Research Fellow in Wound Healing at University of Adelaide. He is also a Principal Scientist at PolyNovo Biomaterials Pty Ltd. His research integrates cell therapy and biomaterials to develop frontier technologies for improved wound care, and management of clinical infection and wound biofilms. He leads a team focused on preclinical studies aimed at developing disruptive technologies and innovative medical devices to improve patient outcomes and reimagine the standard of care.

Profile photo

Susan Volk
Professor of Small Animal Surgery, University of Pennsylvania School of Veterinary Medicine

Susan Volk VMD, PhD, DACVS is the Corinne R and Henry Bower Endowed Professor of Small Animal Surgery at the University of Pennsylvania School of Veterinary Medicine. As a veterinary surgeon-scientist, she is interested in developing innovative translational strategies which close clinical gaps in patient care, particularly when “the scalpel doesn’t cut it.” Her research program focuses on understanding dynamic reciprocity between cells and their surrounding extracellular matrix in both regenerative and tumor microenvironments. The success of her program capitalizes on her ability to lead a cross-disciplinary collaborative team capable of efficiently developing novel therapies for surgical and cancer patients, including her patented approach to reengineering the tumor microenvironment. This National Institutes of Health, private foundation, and industry-sponsored research has basic and translational components, including clinical trials in veterinary patients.

Profile photo

Xanthe Venn
Senior Research Fellow, Future Industries Institute

Dr Xanthe Venn is Senior Research Fellow in Regenerative Medicine at Adelaide University’s Future Industries Institute (FII) and Vice President of the Australasian Wound and Tissue Repair Society (AWTRS). Awarded her PhD from the University of South Australia for the investigation of the role of the cytoskeletal protein Flightless I in tissue regeneration in 2016, Xanthe has more than 30 peer-reviewed publications and received over $1.5 million in research income. A molecular biologist with a deep research background in impaired wound healing, her research in burns, fibrosis and chronic non-healing wounds has been recognised nationally and internationally having won Young Investigator awards from both the AWTRS and European Tissue Repair Society (ETRS) and named a South Australian Young Tall Poppy of Science. Currently, there are no effective diagnostic tools to predict whether a patient will develop a chronic non-healing wound or suffer from debilitating scar formation, nor effective treatments to prevent this. Therefore, Xanthe is working closely with both clinicians and industry to improve healing outcomes for burns patients and reduce the risk of amputation and increased mortality due to non-healing wounds for diabetic patients.

Profile photo

Katharina Richter
Theme Lead Pharmaceutical Sciences, Adelaide University

Associate Professor Katharina Richter is an enthusiastic biomedical scientist, entrepreneur, and medical innovator on a mission to outsmart superbugs and transform healthcare. With a background in pharmacy and a PhD in medicine/applied microbiology, she leads a research group at Adelaide University focused on real-world solutions to antibiotic resistance. Her innovations have already progressed to 3 clinical trials and 1 industry field trial, improving patient care and food safety.

Katharina has lived and worked in 7 countries and collaborates with scientists, clinicians and industry to push research from bench to bedside. A passionate science communicator and mentor, she champions the next generation of STEM leaders through outreach, workshops, and public engagement.

Profile photo

Emma Solly
Postdoctoral Research Scientist, South Australian Health & Medical Research Institute

Dr Emma Solly is a postdoctoral research scientist at the South Australian Health & Medical Research Institute and Adelaide University. Her research in diabetes-related vascular biology has led to first-time discoveries in diabetes-impaired angiogenesis, identifying novel molecular regulators with high translational potential to improve diabetes-related wound healing and vascular outcomes.

She completed her undergraduate degrees at Flinders University (Bachelor of Medical Science and Bachelor of Science (Hons)), where she was awarded the Flinders University Medal for academic achievement. She completed her PhD at the University of Adelaide in 2023, receiving the University Doctoral Research Medal and Dean’s Commendation for Doctoral Thesis Excellence. Her leadership roles on the Australian Cardiovascular Alliance Emerging Leaders Committee (2024-2025) and Director on the Australian Society for Medical Research Board (2025) underscore her growing contributions to the field.

You can only register one delegate at a time.
If you need to change your registration, please remove it from your cart then select the new registration type from the Shop page.

 

Return to Shop

Go to Cart

Profile photo

Fiona Wood
Director of the Burns Service of Western Australia

Prof. Dr. Fiona M. Wood has been a burns surgeon and researcher for over 30 years and is Director of the Burns Service of Western Australia. She is a Consultant Plastic Surgeon at Fiona Stanley Hospital and Perth Children’s Hospital; Winthrop Professor in the School of Surgery at The University of Western Australia; and co-founder of the Fiona Wood Foundation (formerly The McComb Foundation). Professor Wood leads the Paediatric Burn Care team at Telethon Kids Institute and is Co-Head of the Perioperative Care Research Program.

Professor Wood’s has made a significant contribution with her work with co-inventor Marie Stoner, inventing the innovative ‘spray-on skin’ technique (Recell), awarded  the Clunies Ross award by the ATSE.

Fiona was named a Member of the Order of Australia (AM) in 2003 in recognition of the response to the Bai bombing. In 2004 she was awarded the Western Australia Citizen of the Year award for her contribution to Medicine in the field of burns research. Fiona was then named Australian of the Year for 2005. She is an Australian Living Treasure. She is a founding Fellow of the Australian Academy of Health and Medical Science and the 2022 Australian Society of Medical Research medallist. Her continued work has led to the being awarded an officer of the Order of Australia (AO) and being inducted into the WA science hall of fame in 2024.

    To request your accommodation at Mantra Lorne at the discounted conference rate please provide the information below. All bookings are subject to availability. Prices are in Australian dollars and include GST. These prices will be held until 29 June 2025 after which time they can't be guaranteed.

    Arrival Date:

    Departure Date:

    Accommodation Type Required:

    Note: Tariff is per room per night and includes one breakfast per guest

    Optional Room Upgrades:

    Number of Rooms Required:

    Anything else we should know:

    Your browser should display a 'Thank You' message if your booking request was received successfully and you will receive an email confirming the details you supplied. Your booking request will be sent to the Mantra Lorne accommodation team who will contact you directly to finalise your booking and arrange payment. If you experience any problems please contact us and we'll gladly assist.


    Yuval Rinkevich
    Director of the Helmholtz Institute of Regenerative Biology and Medicine at the Helmholtz Center, Munich, Germany

    Dr. Rinkevich has been working at the cutting edge of our understanding of tissue/organ repair and regeneration for the last 20 years. The scientific focus of the Rinkevich lab lies in identifying principles of tissue/organ repair and regeneration, and developing a knowledge foundation for therapeutic strategies in clinical use. His lab explores the stem cells, cellular lineages and mechanisms by which tissues/organs repair and regenerate following injury.

    His passion for healing responses and tissue rejuvenation can be traced throughout his career track, obtaining his PhD degree from the Technion-Israel Institute of Technology, where he studied whole body regeneration from single blood vessels in Protochordates. Dr Rinkevich moved to Stanford University in the US to join the renowned immunology lab of Prof. Irving L. Weissman, where he explored the cellular lineages and stem cells in mammalian tissue repair and regeneration. His work at Stanford projected Dr Rinkevich into the forefront of the tissue repair field for his pioneering work uncovering the role of fibroblast lineages in the transition from scarless to scar forming tissue responses.

    Today Dr Rinkevich is the Director of the Helmholtz Institute of Regenerative Biology and Medicine at the Helmholtz Center, Munich, Germany. His lab continues to push forward our understanding of tissue/organ repair and regeneration. His latest work describing the fascia in tissue fibrosis in multiple organ systems is reinventing the way we look at tissue repair and regeneration, opening our minds to a revolution in antifibrotic therapy and the potential to prevent and potentially resolve fibrotic disease.

    AWTRS 2026 Conference Updates

     

    Enter your details below to learn about the latest developments as we prepare our 2026 meeting.